Výsledky vyhledávání - "Marie Stentebjerg, Decara"

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12–17 Years, With First Episode Psychosis

Autor: Jens Richardt Møllegaard, Thomas Werge, Karsten Gjessing Jensen, Ditte Rudå, Gesche Jürgens, Birgitte Fagerlund, Dea Gowers Klauber, Kristian Linnet, Anne Katrine Pagsberg, Marie Stentebjerg Decara, Anders Fink-Jensen, Christoph U. Correll

Publikováno v: Journal of Clinical Psychopharmacology. 41:667-672

Purpose/background The aim of this study was to examine the association between genetically predicted CYP2D6 phenotypes and extrapyramidal symptoms (EPSs). Methods/procedures Data from the Tolerability and Efficacy of Antipsychotics trial of adolesce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1586848ca88f9942f1b6d2d847f4b0ed
https://doi.org/10.1097/jcp.0000000000001490

Zobrazit plný text záznamu

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years

Publikováno v: Psychological Medicine. 51:1570-1580

BackgroundThe typical onset of schizophrenia coincides with the maturational peak in cognition; however, for a significant proportion of patients the onset is before age 18 and after age 30 years. While cognitive deficits are considered core features

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b0bda4349618385ac5f2515659756e
https://doi.org/10.1017/s0033291720000409

Zobrazit plný text záznamu

Autor: Ditte, Rudå, Karsten Gjessing, Jensen, Marie Stentebjerg, Decara, Dea Gowers, Klauber, Birgitte, Fagerlund, Jens Richardt, Møllegaard, Kristian, Linnet, Thomas, Werge, Christoph U, Correll, Anders, Fink-Jensen, Gesche, Jürgens, Anne Katrine, Pagsberg

Publikováno v: Journal of clinical psychopharmacology. 41(6)

The aim of this study was to examine the association between genetically predicted CYP2D6 phenotypes and extrapyramidal symptoms (EPSs).Data from the Tolerability and Efficacy of Antipsychotics trial of adolescents with first-episode psychosis random

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c28a60f945f2521b16e816ed641c0239
https://pubmed.ncbi.nlm.nih.gov/34735099

Zobrazit plný text záznamu

Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial

Autor: Anne Katrine Pagsberg, Amanda Krogmann, Pia Jeppesen, Laura von Hardenberg, Dea G. Klauber, Karsten Gjessing Jensen, Ditte Rudå, Marie Stentebjerg Decara, Jens Richardt Møllegaard Jepsen, Birgitte Fagerlund, Anders Fink-Jensen, Christoph U. Correll, Britta Galling

Publikováno v: Journal of the American Academy of Child and Adolescent Psychiatry. 61(8)

To evaluate 1) whether early nonresponse to antipsychotics predicts nonresponse and nonremission, 2) patient and illness characteristics as outcome predictors, and 3) response prediction of 30-item Positive and Negative Syndrome Scale (PANSS-30) comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b04e4b0f5735a282b8112a4cf4d8c61
https://pubmed.ncbi.nlm.nih.gov/35470031

Zobrazit plný text záznamu

O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL

Autor: Dea Gowers Klauber, Anne Katrine Pagsberg, Jens Richardt Møllegaard Jepsen, Gjessing Jensen Karsten, Ditte Rudaa, Frank Eriksson, Marie Stentebjerg Decara, Birgitte Fagerlund, Anders Fink-Jensen, Christoph U. Correll

BACKGROUND: Children and adolescents are more prone to develop adverse effects during antipsychotic treatment than adults. The purpose of this paper iso investigate cardiometabolic effects and its predictors in youth with first-episode psychosis (FEP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a51ca1ad3c32d3e0472770a9907afa
https://europepmc.org/articles/PMC6455381/

Zobrazit plný text záznamu

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial

Autor: Karsten Gjessing Jensen, Marie Stentebjerg Decara, Frank Eriksson, Birgitte Fagerlund, Dea Gowers Klauber, Anne Katrine Pagsberg, Ditte Rudå, Jens Richardt Møllegaard Jepsen, Anders Fink-Jensen, Christoph U. Correll

Publikováno v: Journal of the American Academy of Child and Adolescent Psychiatry. 58(11)

To investigate cardiometabolic effects and their predictors in youths with first-episode psychosis (FEP) treated with quetiapine-extended release (ER) versus aripiprazole.Youths with FEP who were 12 to 17 years of age were randomized to quetiapine-ER

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae15e9995ea4eed07dbaedb1f72d63c
https://pubmed.ncbi.nlm.nih.gov/30928730

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání